Theriva Biologics, Inc. Accrued Employee Benefits, Current
Theriva Biologics, Inc. (TOVX) had Accrued Employee Benefits, Current of $208.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Employee-related Liabilities, Current
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2026-08-11
- 2026-06-30: Accrued Employee Benefits, Current $208.00K.
- 2026-03-31: Accrued Employee Benefits, Current $205.00K.
- 2025-12-31: Accrued Employee Benefits, Current $153.00K.
- 2025-09-30: Accrued Employee Benefits, Current $616.00K.
| Period end | Accrued Employee Benefits, Current |
|---|---|
| 2026-06-30 | $208.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $205.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $153.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $616.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $201.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $234.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $187.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $181.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $190.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $224.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $127.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $206.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $350.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $182.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $87.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $106.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $118.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $83.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $978.00K 10-K · filed 2022-03-16 |
| 2021-09-30 | $721.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $540.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $350.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $868.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | $752.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $927.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $309.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $935.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $619.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $511.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $341.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.33M 10-K · filed 2020-02-20 |
| 2018-09-30 | $1.43M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.36M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.02M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.07M 10-K · filed 2019-02-27 |
| 2017-09-30 | $1.61M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $1.21M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $787.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $313.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | $1.34M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.17M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $869.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $277.00K 10-K · filed 2017-03-02 |
| 2015-09-30 | $314.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $394.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $228.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $538.00K 10-K · filed 2016-03-10 |
| 2013-12-31 | $3.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |